Metabolic Disease Clinical Trial
Official title:
The Effects of a Single Day of Mixed Macronutrient Overfeeding on Energy Balance and Metabolic Responses in Healthy Young Men
Healthy male participants are recruited to observe potentially deleterious changes in appetite regulation and metabolic control. Participants will be provided with an energy intake representative of their daily requirements on the first day of one trial and will be provided with an additional 50% energy intake on the first day of another trial. Outcome variables will be assessed during the second day of each trial in response to a fixed mixed macronutrient meal tolerance test.
All testing will take place within the Carnegie Research Institute, Leeds Beckett University.
We will ask all the participants to visit on five occasions for the completion of a
preliminary screening trial and two single-blind counterbalanced experimental trials which
each require the participants to visit the laboratory on two consecutive days. The
experimental trials will be separated by a minimum of one week.
Visit 1: Preliminary Screening:
Before an individual can take part in the experiment, they will need to undergo screening.
Individuals will need to complete a Health Screen Questionnaire. Individuals will be excluded
from the study if they are not currently in good health, have any condition that would alter
their metabolism and/or have had significant medical problems in the past that may affect the
outcomes of the study. Individuals will also be asked to be complete a Three-Factor Eating
Questionnaire, to check that they are not restrained eaters, and an International Physical
Activity Questionnaire (IPAQ) to ensure that all participants are either sedentary or
moderately active. All individuals will be asked to confirm that they have been weight stable
for at least six months before participating and that they are not currently dieting. Height,
body mass and age will be collected to calculate the energy requirements for the main trials
based on the Mifflin equation.
Visits 2, 3, 4 and 5: Experimental Trials:
The participants will be asked to record their food intakes and activity patterns during the
three days prior to the first experimental test using a food and physical activity diary.
They will then be instructed to repeat this diet and activity pattern prior to the second
experimental trial. Participants will be required to arrive at the laboratory for all
experimental trials after an overnight fast of at least 10 hours and having refrained from
any strenuous activity for 48 hours, and alcohol and caffeine consumption in the previous 24
hours. Two hours before arriving at the laboratory on the day of the experimental trials,
participants will be required to ingest 300 mL of water to standardise hydration levels for
the trial.
During Day One of each experimental trial, participants will consume a porridge-based
breakfast, soup- and pasta-based lunch, and rice-based evening meal under laboratory
observation. The meals will contain macronutrient contents representative of current dietary
recommendations of 50% carbohydrate, 15% protein and 35% fat. These meals have been selected
to facilitate manipulation of the energy content, while matching the meals for appearance and
palatability. During one trial, these meals will provide the calculated energy requirement
for each individual based on the Mifflin equation and a physical activity factor of 1.4. The
meals will be covertly manipulated to provide an additional 50% energy intake during the
other trial. The provision of 150% of the estimated energy requirements for participants has
been used in previous research for five day periods but will only be provided for a single
day in the present study. Participants will be required to consume all of the diet during the
standardised phase (i.e. either their daily energy requirements or the 50% overfeed) and will
be blinded to the energy content of the trials. After the consumption of the evening meal
(~6pm), participants will have fulfilled the requirements for day one and will be asked not
to consume any food prior to returning to the laboratory between 7am and 9am the next
morning.
On Day Two of each experimental trial day, participants will arrive at the laboratory after
an overnight fast and an Introcan Safety Cannula will be placed into a vein in the
anticubital space for regular venous blood sampling. Blood samples will be collected in the
fasted state and every 30 min after consumption of a standardised breakfast for a period of
three hours. After the collection of the final blood sample, the cannula will be removed and
participants will be provided with an ad libitum pasta meal (50% carbohydrate, 15% protein,
35% fat) for the assessment of energy intake. Participants will consume ad libitum meals in
isolation to prevent any social influences and will be instructed to eat until 'satisfied'.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06188728 -
Husk Fiber Intervention on Metabolic Health of Centrally Obese School Teachers
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05081037 -
Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)
|
N/A | |
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
Not yet recruiting |
NCT05461144 -
AI Models for Non-invasive Glycaemic Event Detection Using ECG in Type 1 Diabetics
|
||
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A | |
Active, not recruiting |
NCT05505994 -
The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin
|
Phase 3 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03675360 -
Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial
|
N/A | |
Recruiting |
NCT05711758 -
Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
|
||
Recruiting |
NCT05112029 -
Metabolic Profile and Adipokine Levels in Young Hyperandrogenemic Females
|
||
Recruiting |
NCT03682640 -
Azithromycin Insulin Diet Intervention Trial in Type 1 Diabetes
|
Phase 2 | |
Completed |
NCT04854603 -
Dairy Products With Reduced Sugar and Blood Glucose
|
N/A | |
Recruiting |
NCT06024291 -
Reducing Circulating Sphingolipid Levels to Optimise Cardiometabolic Health - The SphingoFIT Trial
|
N/A | |
Recruiting |
NCT04904601 -
Freeze-dried Kale to Reduce Metabolic Risk in Saudi Subjects
|
N/A | |
Recruiting |
NCT04109586 -
Diet and Fat Mass After Traumatic Spinal Cord Injury
|
N/A | |
Recruiting |
NCT06009653 -
Effect of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With Obesity
|
Phase 4 | |
Completed |
NCT03067012 -
Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery for Obese Gastric Cancer Patients
|
N/A | |
Recruiting |
NCT03309423 -
Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU?
|
N/A |